Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (8) , 898-901
- https://doi.org/10.1016/0277-5379(90)90195-y
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell linesin vivo andin vitroCancer, 1989
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.Journal of Clinical Oncology, 1987
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patientsThe American Journal of Medicine, 1986
- The response to chemotherapy of a variety of human tumour xenograftsBritish Journal of Cancer, 1983
- Growth characteristics of human colorectal tumours during serial passage in immune-deprived miceBritish Journal of Cancer, 1978
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972
- Vinblastine in the management of testicular cancerCancer, 1970